Aug 29 (Reuters) – Mylan NV said on Monday it would
launch the first generic to its allergy auto-injector EpiPen at
a discount of more than 50 percent to the branded product’s list
price.
The post Mylan to launch first generic to EpiPen allergy injection appeared first on NASDAQ.